Pharma channel feed – Endpoints News

Pharma channel feed

French health products agency yanked into legal battle over birth defects caused by Sanofi's Depakine

5 years ago

Government gears for unprecedented challenge of Eli Lilly antibody rollout as efficacy questions linger

5 years ago

Bristol Myers posts another win for their Otezla competitor, this time with PhII data in psoriatic arthritis

5 years ago

Endo Pharmaceuticals chops 560 jobs to refocus on cellulite drug launch

5 years ago

An election night bereft of answers quells biopharma's 'worst-case' fears — analysts

5 years ago

Prevail and Alector both claim victory in arbitration over scientist-CEO, telling divergent tales of confidential hearings

5 years ago

Small cap immunotherapy player Ziopharm faces an activist attack, rebukes call for board seats

5 years ago

Novo Nordisk quietly nabs a rare 'breakthrough' status in NASH for its cash cow

5 years ago

Sanofi teams up with Merck to pair Keytruda with a next-gen IL-2 candidate from the Synthorx buyout

5 years ago

Once rejected, Kala's dry eye drug now gains entry to a field where Novartis is grooming its own blockbuster

5 years ago

Indivior's Shaun Thaxter heads to prison, joining Insys' John Kapoor among jailed opioid execs

5 years ago

FDA anoints Gilead's remdesivir as the Covid-19 treatment winner, handing down full approval — despite some deep skepticism

5 years ago

Roche finds a home for a new, $500M manufacturing logistics hub, promising 500 jobs

5 years ago

What about the German negotiation model? Biden steers drug pricing debate to a showdown

5 years ago

Super-secretive anti-aging biotech Calico tees up the first visible clinical trial of an experimental drug. And it’s for cancer?

5 years ago

UCB sketches grand plans for new headquarters as it grabs Eli Lilly's abandoned neuro R&D campus

5 years ago

The prospect of an October OK largely closed, Pfizer's Albert Bourla promises not to submit for EUA until November

5 years ago

Vaxart was served a grand jury subpoena in July over its controversial role in OWS-funded preclinical study

5 years ago

Sami Anwar raked in millions of dollars gathering drug trial data at his sites. But it was all a lie — and now he's been sentenced to 28 years

5 years ago

Drowning in litigation, Mallinckrodt becomes third opioid producer to file for bankruptcy

5 years ago

As Trump touts his ‘great’ Covid drugs, the pharma cash flows to Biden, not him

5 years ago

Seattle Genetics? Not anymore. The biotech has shortened its name to Seagen to illustrate global expansion

5 years ago

Opdivo/Yervoy combo flops again in melanoma, but Bristol Myers Squibb also has a new OK to celebrate

5 years ago

Ransomware attack hit clinical trials software player ERT — two weeks later, they’re coming back online

5 years ago

First page Previous page 253 254 255256257 258 259 Next page Last page